melanotan studies MT 1 | 10 MG What Is Melanotan II (MT2)?
Description
Get a FREE 15-minute Virtual Protocol Review + our Regenerative Treatment Newsletter
Although there was a high rate of adverse effects (27%), 39% had a favorable on-treatment response and 21% developed an SVR (11% in genotype 1 and 50% in genotype 2 and 3), all of whom remained virus-free post-transplantation
(2021) 93:e12998
